• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Walker 256癌肉瘤大鼠体内N-1-甲基烟酰胺分布与排泄的改变

Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.

作者信息

Clark B R, Murai J T, Pomeranz A, Mills P A, Halpern R M

出版信息

Cancer Res. 1975 Jul;35(7):1727-33.

PMID:236826
Abstract

Levels of nicotinamide and N-1-methylnicotinamide in serum, liver, and kidney as well as renal clearances and 24-hr urine levels of N-1-methylnicotinamide were compared in normal rats and rats bearing Walker 256 tumors. There was no significant difference between normal and tumor-bearing rats with regard to nicotinamide levels. With regard to N-1-methylnicotinamide, tumor-bearing rats had significantly lower serum and liver levels and significantly higher 24-hr urine levels and renal clearances. Walker 256 tumor tissue and liver and kidney from a normal and a tumor-bearing rat were separately examined for S-adenosylmethionine:nicotinamide methyltransferase activity. The specific activity in tumor tissue extract was greater than that in each liver extract, which, in turn, was much greater than the specific activity in each tissue (liver and kidney) from the tumor-bearing rat was equal to the specific activity in the corresponding tissue of the normal rat. S-adenosylmethionine:nicotinamide methyltransferase was obtained with 18-fold purification from a tissue extract of Walker 256 tumor. The enzyme activity required activation by thiols, and maximal activity was observed at pH 8.6. The Km's for the substrates, S-adenosylmethionine and nicotinamide, were 7.0 x 10--3 mM and 0.50 mM respectively. The Ki's for the products, S-adenosylhomocysteine and N-1-methylnicotinamide, were respectively, 25 x 10--3 mM and greater than 5 mM.

摘要

比较了正常大鼠和荷Walker 256肿瘤大鼠血清、肝脏和肾脏中烟酰胺和N-1-甲基烟酰胺的水平,以及N-1-甲基烟酰胺的肾清除率和24小时尿水平。在烟酰胺水平方面,正常大鼠和荷瘤大鼠之间没有显著差异。关于N-1-甲基烟酰胺,荷瘤大鼠的血清和肝脏水平显著降低,24小时尿水平和肾清除率显著升高。分别检测了正常大鼠和荷瘤大鼠的Walker 256肿瘤组织以及肝脏和肾脏中的S-腺苷甲硫氨酸:烟酰胺甲基转移酶活性。肿瘤组织提取物中的比活性大于每个肝脏提取物中的比活性,而每个肝脏提取物中的比活性又远大于荷瘤大鼠每个组织(肝脏和肾脏)中的比活性,荷瘤大鼠相应组织中的比活性与正常大鼠的相等。从Walker 256肿瘤的组织提取物中以18倍纯化获得了S-腺苷甲硫氨酸:烟酰胺甲基转移酶。该酶活性需要硫醇激活,在pH 8.6时观察到最大活性。底物S-腺苷甲硫氨酸和烟酰胺的Km值分别为7.0×10⁻³ mM和0.50 mM。产物S-腺苷同型半胱氨酸和N-1-甲基烟酰胺的Ki值分别为25×10⁻³ mM和大于5 mM。

相似文献

1
Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.Walker 256癌肉瘤大鼠体内N-1-甲基烟酰胺分布与排泄的改变
Cancer Res. 1975 Jul;35(7):1727-33.
2
[Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors].[正常大鼠、荷瘤大鼠器官及肿瘤中烟酰胺腺嘌呤二核苷酸(NAD)生物合成的基础途径和补救途径]
Vopr Onkol. 1994;40(1-3):68-71.
3
The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production.人类肝硬化中烟酰胺的代谢:关于N-甲基烟酰胺和2-吡啶酮-5-甲酰胺生成的研究
Am J Gastroenterol. 2001 Apr;96(4):1183-7. doi: 10.1111/j.1572-0241.2001.03698.x.
4
Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.一种新型三嗪类抗叶酸剂在小鼠、大鼠、狗和猴子体内的药理学研究
Cancer Res. 1975 Jan;35(1):17-22.
5
Characterization of glycine N-methyltransferase from rabbit liver.兔肝脏甘氨酸N-甲基转移酶的特性分析
Biochem Cell Biol. 2004 Jun;82(3):369-74. doi: 10.1139/o04-007.
6
[Activity of 5-alpha- and 5-beta-steroid reductases in subcellular liver structures from rats bearing Walker carcinosarcoma].
Vopr Med Khim. 1989 Jan-Feb;35(1):77-81.
7
The relationship of the cyclic nucleotide system to inhibition of hepatic drug metabolism in Walker 256 carcinoma-bearing rats.环核苷酸系统与Walker 256荷癌大鼠肝脏药物代谢抑制的关系。
Res Commun Chem Pathol Pharmacol. 1980 Oct;30(1):71-89.
8
Ethionine alters the urinary excretion of N1-methylnicotinamide.乙硫氨酸会改变N1-甲基烟酰胺的尿排泄。
Cancer Lett. 1981 Nov;14(2):137-42. doi: 10.1016/0304-3835(81)90123-3.
9
[S35 lipoic acid distribution and its effect on pyruvate dehydrogenase activity in rats with Walker carcinoma].[S35硫辛酸在Walker癌大鼠中的分布及其对丙酮酸脱氢酶活性的影响]
Vopr Onkol. 1977;23(10):87-90.
10
[Interaction of glucocorticoids with receptors of rat liver cells during the growth of Walker carcinosarcoma].
Vopr Med Khim. 1987 Jan-Feb;33(1):33-40.

引用本文的文献

1
Nicotinamide -Methyltransferase in Health and Cancer.健康与癌症中的烟酰胺 - 甲基转移酶
Int J Tryptophan Res. 2017 Jun 30;10:1178646917691739. doi: 10.1177/1178646917691739. eCollection 2017.
2
Metabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver Tumors.VX2兔继发性肝肿瘤模型肝组织的代谢组学分析
HPB Surg. 2014;2014:310372. doi: 10.1155/2014/310372. Epub 2014 Mar 2.
3
Metabolism: Cancer mistunes methylation.代谢:癌症扰乱甲基化。
Nat Chem Biol. 2013 May;9(5):293-4. doi: 10.1038/nchembio.1234.
4
N1-methylnicotinamide level in the blood after nicotinamide loading as further evidence for malignant tumor burden.烟酰胺负荷后血液中N1-甲基烟酰胺水平作为恶性肿瘤负荷的进一步证据。
Jpn J Cancer Res. 1991 Nov;82(11):1277-83. doi: 10.1111/j.1349-7006.1991.tb01793.x.